Advanced searches left 3/3

Flecainide - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 07 August 2022

* If you want to update the article please login/register

Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia

The interventional phase is followed by an observational phase as long as the patient is implanted with the ICM, but only the device's data will be collected. Screening and selection takes place before the PFO's closure is finalized, and an informed consent form is signed. Patients who will have the ICM for a long time after a 6-month follow-up period have an observational period.

Source link: https://clinicaltrials.gov/ct2/show/NCT05213104

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions